AU2007305134B2 - Implantable device for responsive neural stimulation therapy - Google Patents
Implantable device for responsive neural stimulation therapy Download PDFInfo
- Publication number
- AU2007305134B2 AU2007305134B2 AU2007305134A AU2007305134A AU2007305134B2 AU 2007305134 B2 AU2007305134 B2 AU 2007305134B2 AU 2007305134 A AU2007305134 A AU 2007305134A AU 2007305134 A AU2007305134 A AU 2007305134A AU 2007305134 B2 AU2007305134 B2 AU 2007305134B2
- Authority
- AU
- Australia
- Prior art keywords
- neural stimulation
- duty cycle
- patient
- programmed
- stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 168
- 230000001537 neural effect Effects 0.000 title claims abstract description 134
- 238000002560 therapeutic procedure Methods 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000002567 autonomic effect Effects 0.000 claims abstract description 9
- 230000000747 cardiac effect Effects 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 20
- 210000002216 heart Anatomy 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 230000000241 respiratory effect Effects 0.000 claims description 15
- 230000001515 vagal effect Effects 0.000 claims description 9
- 230000007423 decrease Effects 0.000 claims description 8
- 230000001186 cumulative effect Effects 0.000 claims description 5
- 230000036387 respiratory rate Effects 0.000 claims description 5
- 230000036772 blood pressure Effects 0.000 claims description 4
- 230000003434 inspiratory effect Effects 0.000 claims description 4
- 206010019280 Heart failures Diseases 0.000 abstract description 11
- 230000002889 sympathetic effect Effects 0.000 abstract description 10
- 230000001734 parasympathetic effect Effects 0.000 abstract description 7
- 230000006870 function Effects 0.000 description 8
- 210000005036 nerve Anatomy 0.000 description 8
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 7
- 210000001186 vagus nerve Anatomy 0.000 description 7
- 208000033774 Ventricular Remodeling Diseases 0.000 description 6
- 208000010125 myocardial infarction Diseases 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 230000001746 atrial effect Effects 0.000 description 5
- 108091008698 baroreceptors Proteins 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 210000001774 pressoreceptor Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000012806 monitoring device Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 230000008602 contraction Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000000574 ganglionic effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000036316 preload Effects 0.000 description 3
- 238000007634 remodeling Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 238000013194 cardioversion Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 210000003626 afferent pathway Anatomy 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000035581 baroreflex Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000001326 carotid sinus Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- WABPQHHGFIMREM-AKLPVKDBSA-N lead-210 Chemical compound [210Pb] WABPQHHGFIMREM-AKLPVKDBSA-N 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000002644 neurohormonal effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008701 parasympathetic activation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 210000003291 sinus of valsalva Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/539,289 US7925342B2 (en) | 2006-10-06 | 2006-10-06 | Implantable device for responsive neural stimulation therapy |
| US11/539,289 | 2006-10-06 | ||
| PCT/US2007/070180 WO2008042476A1 (en) | 2006-10-06 | 2007-06-01 | Implantable device for responsive neural stimulation therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007305134A1 AU2007305134A1 (en) | 2008-04-10 |
| AU2007305134B2 true AU2007305134B2 (en) | 2012-01-19 |
Family
ID=38671004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007305134A Ceased AU2007305134B2 (en) | 2006-10-06 | 2007-06-01 | Implantable device for responsive neural stimulation therapy |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7925342B2 (https=) |
| EP (1) | EP2073895B1 (https=) |
| JP (1) | JP5015256B2 (https=) |
| CN (1) | CN101522260B (https=) |
| AU (1) | AU2007305134B2 (https=) |
| WO (1) | WO2008042476A1 (https=) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5549590A (en) | 1989-05-11 | 1990-11-29 | Landec Labs, Inc. | Temperature-activated adhesive assemblies |
| US7801604B2 (en) | 2006-08-29 | 2010-09-21 | Cardiac Pacemakers, Inc. | Controlled titration of neurostimulation therapy |
| US7925342B2 (en) | 2006-10-06 | 2011-04-12 | Cardiac Pacemakers, Inc. | Implantable device for responsive neural stimulation therapy |
| US9089700B2 (en) * | 2008-08-11 | 2015-07-28 | Cibiem, Inc. | Systems and methods for treating dyspnea, including via electrical afferent signal blocking |
| US9079031B2 (en) * | 2008-09-11 | 2015-07-14 | Trifectas Medical Corp. | Method for improving functional recovery after stroke by electrical stimulation of a cranial nerve |
| US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
| WO2010054116A1 (en) * | 2008-11-10 | 2010-05-14 | Cardiac Pacemakers, Inc. | Distal end converter for a medical device lead |
| EP2408518A1 (en) * | 2009-03-09 | 2012-01-25 | Cardiac Pacemakers, Inc. | Systems for autonomic nerve modulation comprising electrodes implantable in a lymphatic vessel |
| US8463377B2 (en) * | 2009-05-26 | 2013-06-11 | Cardiac Pacemakers, Inc. | Temperature assisted stimulation |
| US8954167B2 (en) * | 2009-05-26 | 2015-02-10 | Cardiac Pacemakers, Inc. | Helically formed coil for a neural cuff electrode |
| EP2454697B1 (en) | 2009-07-15 | 2019-05-01 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
| WO2011008749A2 (en) | 2009-07-15 | 2011-01-20 | Cardiac Pacemakers, Inc. | Physiologicl vibration detection in an implanted medical device |
| EP2453975B1 (en) * | 2009-07-15 | 2016-11-02 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
| EP3002037B1 (en) | 2010-09-15 | 2018-06-06 | Cardiac Pacemakers, Inc. | Automatic selection of lead configuration for a neural stimulation lead |
| US9026214B2 (en) | 2011-06-23 | 2015-05-05 | Cardiac Pacemakers, Inc. | Systems and methods for avoiding aspiration during autonomic modulation therapy |
| EP2726142B1 (en) | 2011-06-28 | 2017-05-10 | Cardiac Pacemakers, Inc. | Strain relief feature for an implantable medical device lead |
| AU2012279403B2 (en) | 2011-07-07 | 2015-05-28 | Cardiac Pacemakers, Inc. | Insulation and stability features for an implantable medical device lead |
| US8577458B1 (en) | 2011-12-07 | 2013-11-05 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring |
| US8918191B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| US8918190B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction |
| US8630709B2 (en) | 2011-12-07 | 2014-01-14 | Cyberonics, Inc. | Computer-implemented system and method for selecting therapy profiles of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| US8600505B2 (en) | 2011-12-07 | 2013-12-03 | Cyberonics, Inc. | Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| US10188856B1 (en) | 2011-12-07 | 2019-01-29 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| AU2012351954B2 (en) | 2011-12-15 | 2016-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and methods for treating pulmonary hypertension |
| US8571654B2 (en) | 2012-01-17 | 2013-10-29 | Cyberonics, Inc. | Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction |
| US8700150B2 (en) | 2012-01-17 | 2014-04-15 | Cyberonics, Inc. | Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| JP2013165768A (ja) * | 2012-02-14 | 2013-08-29 | Olympus Corp | 神経刺激装置およびその制御方法 |
| JP6026567B2 (ja) | 2012-03-21 | 2016-11-16 | カーディアック ペースメイカーズ， インコーポレイテッド | 迷走神経を刺激するためのシステムおよび方法 |
| EP2840993A4 (en) | 2012-04-24 | 2016-03-30 | Cibiem Inc | ENDOVASCULAR CATHETERS AND METHOD FOR CAROTID BODY ABLATION |
| WO2013181667A1 (en) | 2012-06-01 | 2013-12-05 | Cibiem, Inc. | Percutaneous methods and devices for carotid body ablation |
| EP2854680A4 (en) | 2012-06-01 | 2016-07-20 | Cibiem Inc | METHODS AND DEVICES FOR ABLATION OF CRYOGENIC CAROTID BODY |
| US9955946B2 (en) | 2014-03-12 | 2018-05-01 | Cibiem, Inc. | Carotid body ablation with a transvenous ultrasound imaging and ablation catheter |
| WO2014005155A1 (en) | 2012-06-30 | 2014-01-03 | Cibiem, Inc. | Carotid body ablation via directed energy |
| US8688212B2 (en) | 2012-07-20 | 2014-04-01 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation |
| EP2903685B1 (en) | 2012-10-02 | 2019-08-07 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
| WO2014055408A1 (en) | 2012-10-02 | 2014-04-10 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
| US9452290B2 (en) | 2012-11-09 | 2016-09-27 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation |
| US8923964B2 (en) | 2012-11-09 | 2014-12-30 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation |
| US9643008B2 (en) | 2012-11-09 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation |
| US9827036B2 (en) | 2012-11-13 | 2017-11-28 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
| US11241267B2 (en) | 2012-11-13 | 2022-02-08 | Pulnovo Medical (Wuxi) Co., Ltd | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
| US12082868B2 (en) | 2012-11-13 | 2024-09-10 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
| CN102908191A (zh) | 2012-11-13 | 2013-02-06 | 陈绍良 | 多极同步肺动脉射频消融导管 |
| EP2928550B1 (en) | 2012-12-07 | 2023-06-07 | Medtronic, Inc. | Minimally invasive implantable neurostimulation system |
| WO2014106023A1 (en) | 2012-12-28 | 2014-07-03 | Cardiac Pacemakers, Inc. | Stimulation cuff and implantation tool |
| US9320889B2 (en) | 2013-02-13 | 2016-04-26 | Cardiac Pacemakers, Inc. | Cuff electrode with integrated tendril |
| US9643011B2 (en) | 2013-03-14 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation |
| US9999773B2 (en) | 2013-10-30 | 2018-06-19 | Cyberonics, Inc. | Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters |
| CN105873504A (zh) * | 2013-11-01 | 2016-08-17 | 美敦力监控公司 | 充血性心力衰竭风险状态确定方法及相关设备 |
| US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
| US9415224B2 (en) | 2014-04-25 | 2016-08-16 | Cyberonics, Inc. | Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction |
| US9713719B2 (en) | 2014-04-17 | 2017-07-25 | Cyberonics, Inc. | Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction |
| US9272143B2 (en) | 2014-05-07 | 2016-03-01 | Cyberonics, Inc. | Responsive neurostimulation for the treatment of chronic cardiac dysfunction |
| US9950169B2 (en) | 2014-04-25 | 2018-04-24 | Cyberonics, Inc. | Dynamic stimulation adjustment for identification of a neural fulcrum |
| US9409024B2 (en) | 2014-03-25 | 2016-08-09 | Cyberonics, Inc. | Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction |
| US9770599B2 (en) | 2014-08-12 | 2017-09-26 | Cyberonics, Inc. | Vagus nerve stimulation and subcutaneous defibrillation system |
| US9737716B2 (en) | 2014-08-12 | 2017-08-22 | Cyberonics, Inc. | Vagus nerve and carotid baroreceptor stimulation system |
| US9533153B2 (en) | 2014-08-12 | 2017-01-03 | Cyberonics, Inc. | Neurostimulation titration process |
| US9504832B2 (en) | 2014-11-12 | 2016-11-29 | Cyberonics, Inc. | Neurostimulation titration process via adaptive parametric modification |
| US9757574B2 (en) | 2015-05-11 | 2017-09-12 | Rainbow Medical Ltd. | Dual chamber transvenous pacemaker |
| WO2017172864A1 (en) * | 2016-04-01 | 2017-10-05 | Cardiac Pacemakers, Inc. | Detection of worsening heart failure |
| CN106075724A (zh) * | 2016-06-12 | 2016-11-09 | 肖波 | 植入式迷走神经双通道刺激装置 |
| US11794012B2 (en) | 2017-07-11 | 2023-10-24 | The General Hospital Corporation | Systems and methods for respiratory-gated nerve stimulation |
| JP7245233B2 (ja) | 2017-09-14 | 2023-03-23 | リヴァノヴァ ユーエスエイ インコーポレイテッド | 植え込み型神経刺激装置のためのカスタマイズ可能な漸増 |
| WO2019126080A1 (en) | 2017-12-18 | 2019-06-27 | Dan Sachs | Devices, systems and methods for therapeutic muscle stimulation |
| US10974079B2 (en) * | 2018-08-29 | 2021-04-13 | General Electric Company | Neuromodulation techniques |
| EP4108197A1 (en) | 2021-06-24 | 2022-12-28 | Gradient Denervation Technologies | Systems for treating tissue |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6141590A (en) * | 1997-09-25 | 2000-10-31 | Medtronic, Inc. | System and method for respiration-modulated pacing |
| EP1486232A2 (en) * | 2002-06-12 | 2004-12-15 | Pacesetter, Inc. | Device for improving cardiac funtion in heart failure or CHF patients |
| US20050143779A1 (en) * | 2003-12-24 | 2005-06-30 | Cardiac Pacemakers, Inc. | Baroreflex modulation based on monitored cardiovascular parameter |
| US20060206154A1 (en) * | 2005-03-11 | 2006-09-14 | Julia Moffitt | Combined neural stimulation and cardiac resynchronization therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6622041B2 (en) | 2001-08-21 | 2003-09-16 | Cyberonics, Inc. | Treatment of congestive heart failure and autonomic cardiovascular drive disorders |
| JP4252826B2 (ja) * | 2003-03-14 | 2009-04-08 | テルモ株式会社 | 心臓治療装置 |
| US20060058852A1 (en) * | 2004-09-10 | 2006-03-16 | Steve Koh | Multi-variable feedback control of stimulation for inspiratory facilitation |
| US8473049B2 (en) * | 2005-05-25 | 2013-06-25 | Cardiac Pacemakers, Inc. | Implantable neural stimulator with mode switching |
| US7925342B2 (en) | 2006-10-06 | 2011-04-12 | Cardiac Pacemakers, Inc. | Implantable device for responsive neural stimulation therapy |
-
2006
- 2006-10-06 US US11/539,289 patent/US7925342B2/en not_active Expired - Fee Related
-
2007
- 2007-06-01 WO PCT/US2007/070180 patent/WO2008042476A1/en not_active Ceased
- 2007-06-01 CN CN2007800375316A patent/CN101522260B/zh not_active Expired - Fee Related
- 2007-06-01 AU AU2007305134A patent/AU2007305134B2/en not_active Ceased
- 2007-06-01 JP JP2009531497A patent/JP5015256B2/ja not_active Expired - Fee Related
- 2007-06-01 EP EP07797984.7A patent/EP2073895B1/en not_active Not-in-force
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6141590A (en) * | 1997-09-25 | 2000-10-31 | Medtronic, Inc. | System and method for respiration-modulated pacing |
| EP1486232A2 (en) * | 2002-06-12 | 2004-12-15 | Pacesetter, Inc. | Device for improving cardiac funtion in heart failure or CHF patients |
| US20050143779A1 (en) * | 2003-12-24 | 2005-06-30 | Cardiac Pacemakers, Inc. | Baroreflex modulation based on monitored cardiovascular parameter |
| US20060206154A1 (en) * | 2005-03-11 | 2006-09-14 | Julia Moffitt | Combined neural stimulation and cardiac resynchronization therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007305134A1 (en) | 2008-04-10 |
| EP2073895B1 (en) | 2017-04-05 |
| WO2008042476A1 (en) | 2008-04-10 |
| CN101522260B (zh) | 2012-10-24 |
| US20080086181A1 (en) | 2008-04-10 |
| JP2010505528A (ja) | 2010-02-25 |
| JP5015256B2 (ja) | 2012-08-29 |
| CN101522260A (zh) | 2009-09-02 |
| US7925342B2 (en) | 2011-04-12 |
| EP2073895A1 (en) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007305134B2 (en) | Implantable device for responsive neural stimulation therapy | |
| AU2007290736B2 (en) | Controlled titration of neurostimulation therapy | |
| US7664548B2 (en) | Distributed neuromodulation system for treatment of cardiovascular disease | |
| US7805193B2 (en) | Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device | |
| AU2011353038B2 (en) | Neuro cardiac therapy using electrical impedance | |
| US20100318154A1 (en) | System and method for testing neural stimulation threshold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |